CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
32.56
-0.12 (-0.37%)
Nov 17, 2026, 1:40 PM CST
SHE:300765 Revenue
CSPC Innovation Pharmaceutical had revenue of 736.21M CNY in the quarter ending September 30, 2026, with 35.47% growth. This brings the company's total for the last twelve months to 4.54B, up 116.78% year-over-year. In the year 2025, CSPC Innovation Pharmaceutical had annual revenue of 2.16B with 8.93% growth. That makes CSPC Innovation Pharmaceutical the 9,538th largest company in the world by revenue and 1,528th in China.
Revenue (ttm)
4.54B
Revenue Growth
+116.78%
P/S Ratio
9.92
Revenue / Employee
1.92M
Employees
2,369
Market Cap
45.34B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:300765 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.16B | 176.93M | 8.93% |
| Dec 31, 2024 | 1.98B | -557.96M | -21.98% |
| Dec 31, 2023 | 2.54B | -87.78M | -3.34% |
| Jan 1, 2023 | 2.63B | 776.81M | 42.00% |
| Jan 1, 2022 | 1.85B | 532.26M | 40.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Yihai Kerry Arawana Holdings | 252.66B |
| Guangdong Haid Group | 135.72B |
| New Hope Liuhe | 114.05B |
| Henan Shuanghui Investment & Development | 57.76B |
| Angel Yeast | 18.55B |
| Anjoy Foods Group | 18.28B |
| New Hope Dairy | 11.66B |
| Byhealth | 6.65B |
CSPC Innovation Pharmaceutical News
- 19 days ago - CSPC Innovation Pharmaceutical Quarterly report: Q3 2026 - Filings
- 3 months ago - CSPC Innovation Pharmaceutical Quarterly report: Q2 2026 - Filings
- 6 months ago - CSPC Innovation Pharmaceutical Quarterly report: Q1 2026 - Filings
- 8 months ago - CSPC Innovation Pharmaceutical Annual report: Q4 2025 - Filings